Advisory Services Network LLC Has $13.04 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisory Services Network LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 24,986 shares of the medical equipment provider’s stock after acquiring an additional 2,886 shares during the quarter. Advisory Services Network LLC’s holdings in Intuitive Surgical were worth $13,042,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Bernard Wealth Management Corp. acquired a new stake in Intuitive Surgical during the 4th quarter valued at $56,000. Bank of Nova Scotia boosted its holdings in Intuitive Surgical by 10.9% in the 4th quarter. Bank of Nova Scotia now owns 187,623 shares of the medical equipment provider’s stock valued at $98,008,000 after purchasing an additional 18,391 shares during the period. Shelton Capital Management grew its holdings in shares of Intuitive Surgical by 8.1% during the 4th quarter. Shelton Capital Management now owns 73,628 shares of the medical equipment provider’s stock worth $38,431,000 after purchasing an additional 5,490 shares in the last quarter. Invesco Ltd. raised its position in shares of Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock valued at $2,165,184,000 after buying an additional 295,025 shares in the last quarter. Finally, Employees Retirement System of Texas increased its stake in Intuitive Surgical by 16.2% in the fourth quarter. Employees Retirement System of Texas now owns 8,346 shares of the medical equipment provider’s stock valued at $4,356,000 after acquiring an additional 1,165 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 2.7 %

Shares of Intuitive Surgical stock opened at $463.62 on Tuesday. The business has a 50 day moving average price of $542.98 and a 200-day moving average price of $532.81. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market cap of $165.13 billion, a PE ratio of 72.33, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ISRG. Evercore ISI boosted their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Citigroup upped their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Robert W. Baird lowered their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.